These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28438823)

  • 21. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese.
    Cheung YK; Cheng SH; Chan EJ; Lo SV; Ng MH; Kwan P
    Epilepsia; 2013 Jul; 54(7):1307-14. PubMed ID: 23692434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic predictors of Stevens-Johnson syndrome and toxic epidermal necrolysis induced by aromatic antiepileptic drugs among the Chinese Han population.
    Wang W; Hu FY; Wu XT; An DM; Yan B; Zhou D
    Epilepsy Behav; 2014 Aug; 37():16-9. PubMed ID: 24949577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.
    Hung SI; Chung WH; Liu ZS; Chen CH; Hsih MS; Hui RC; Chu CY; Chen YT
    Pharmacogenomics; 2010 Mar; 11(3):349-56. PubMed ID: 20235791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis.
    Wu X; Liu W; Zhou W
    J Clin Pharm Ther; 2018 Jun; 43(3):408-413. PubMed ID: 29274302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.
    Tangamornsuksan W; Lohitnavy M
    Pharmacogenomics J; 2019 Jun; 19(3):286-294. PubMed ID: 30242287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population.
    Chang CC; Too CL; Murad S; Hussein SH
    Int J Dermatol; 2011 Feb; 50(2):221-4. PubMed ID: 21244392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.
    Yeo SI
    Int J Rheum Dis; 2013 Jun; 16(3):254-7. PubMed ID: 23981744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a rapid and inexpensive assay for detecting a surrogate genetic polymorphism of HLA-B*58:01: a partially predictive but useful biomarker for allopurinol-related Stevens-Johnson syndrome/toxic epidermal necrolysis in Japanese.
    Maekawa K; Nishikawa J; Kaniwa N; Sugiyama E; Koizumi T; Kurose K; Tohkin M; Saito Y
    Drug Metab Pharmacokinet; 2012; 27(4):447-50. PubMed ID: 22277675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe.
    Génin E; Schumacher M; Roujeau JC; Naldi L; Liss Y; Kazma R; Sekula P; Hovnanian A; Mockenhaupt M
    Orphanet J Rare Dis; 2011 Jul; 6():52. PubMed ID: 21801394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: Signal detection and preventability from Vietnam National pharmacovigilance database.
    Huong PT; Ha TN; Nhu TTQ; Nga NTH; Anh NH; Hoa VD; Binh NQ; Anh NH
    J Clin Pharm Ther; 2022 Dec; 47(12):2014-2019. PubMed ID: 35848069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Cristallo AF; Schroeder J; Citterio A; Santori G; Ferrioli GM; Rossi U; Bertani G; Cassano S; Gottardi P; Ceschini N; Barocci F; Ribizzi G; Cutrupi V; Cairoli R; Rapisarda V; Pastorello EA; Barocci S
    Int J Immunogenet; 2011 Aug; 38(4):303-9. PubMed ID: 21545408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the association of Lamotrigine and Phenytoin-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis with HLA-B*1502 in Iranian population.
    Sabourirad S; Mortezaee R; Mojarad M; Eslahi A; Shahrokhi Y; Kiafar B; Jarahi L; Afkhami Ardakani S; Farrokhi S
    Exp Dermatol; 2021 Feb; 30(2):284-287. PubMed ID: 33217035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic susceptibilities and prediction modeling of carbamazepine and allopurinol-induced severe cutaneous adverse reactions in Vietnamese.
    van Nguyen D; Chu HC; Vidal C; Fulton RB; Nguyen NN; Quynh Do NT; Tran TL; Nguyen TN; Thu Nguyen HT; Chu HH; Thanh Thuc HT; Minh Le HT; van Nunen S; Anderson J; Fernando SL
    Pharmacogenomics; 2021 Jan; 22(1):1-12. PubMed ID: 33356553
    [No Abstract]   [Full Text] [Related]  

  • 34. HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis.
    Khor AH; Lim KS; Tan CT; Wong SM; Ng CC
    Epilepsia; 2014 Nov; 55(11):e120-4. PubMed ID: 25266342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?
    Lee MH; Stocker SL; Anderson J; Phillips EJ; Nolan D; Williams KM; Graham GG; Sullivan JR; Day RO
    Intern Med J; 2012 Apr; 42(4):411-6. PubMed ID: 21790926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of a genotyping technique for a surrogate marker of HLA-B
    Tsukagoshi E; Nakamura R; Tanaka Y; Maekawa K; Hiratsuka M; Asada H; Saito Y
    Drug Metab Pharmacokinet; 2023 Apr; 49():100495. PubMed ID: 36863950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population.
    Saokaew S; Tassaneeyakul W; Maenthaisong R; Chaiyakunapruk N
    PLoS One; 2014; 9(4):e94294. PubMed ID: 24732692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study.
    Syu FK; Pan HY; Chuang PC; Huang YS; Cheng CY; Cheng FJ
    J Dermatol; 2018 Sep; 45(9):1080-1087. PubMed ID: 29963717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans.
    Kang HR; Jee YK; Kim YS; Lee CH; Jung JW; Kim SH; Park HW; Chang YS; Jang IJ; Cho SH; Min KU; Kim SH; Lee KW;
    Pharmacogenet Genomics; 2011 May; 21(5):303-7. PubMed ID: 21301380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
    Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC;
    J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.